Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s First Complete Response Letter Of 2017 Involves … Manufacturing

Jan 13 2017

• By Joseph Haas

Vial Separation Turntable

Related Content

Roche’s Highly Anticipated Ocrelizumab Delayed By Manufacturing Issues

Dec 20 2016

Tesaro's Varubi: Safety, Dosing Convenience Could Drive Third NK-1 Inhibitor

Sep 03 2015

Tesaro's Varubi Wins FDA Approval; Shares Up

Sep 03 2015

Related Companies

Tesaro, Inc.

Merck & Co., Inc.

Additional Topics

United States Complete Response Letters Manufacturing Drug Approval Standards Regulation Review Pathway FDA Drug Review BioPharmaceutical Cancer

More from Complete Response Letters

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window